+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years +
MALE
ID06888102

Study of Epigenetic Therapy Before Prostate Surgery in Men with High-risk Prostate Cancer

Led by Edwin Posadas, MD · Updated on 2026-02-03

20

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are exploring the safety and antitumor effects of epigenetic therapies in men with localized prostate cancer who are scheduled for radical prostatectomy. This early-phase study aims to see if epigenetic treatments can make the tumor more sensitive to the bodys immune response. The study will monitor safety, measure biomarkers, and evaluate clinical activity of these therapies, with specific details for each treatment group provided in separate appendices to the main protocol. Participants will receive one of the epigenetic therapies before surgery, with treatment lasting up to about four weeks or as described in the specific treatment appendix. Therapy continues unless there is disease progression, unacceptable side effects, the maximum treatment duration is reached, or the participant chooses to withdraw. The lead investigators may adjust or add new therapies based on emerging data. During the study, participants will provide consent to use biopsy and prostatectomy tissue for biomarker analysis. They will be closely monitored for safety, treatment response, and any side effects. Researchers will assess outcomes such as treatment safety, toxicity, feasibility of surgery after therapy, and progression-free survival over several years. The study lasts for about two years of safety monitoring, with some outcomes followed for up to seven years after treatment.

CONDITIONS

Brief Title

A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer

Research Team

C

Clinical Trial Navigator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here